Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 3,553 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fluids Clear all

Conditions: Schizophrenia, Schizo Affective Disorder, Schizophreniform Disorders, Psychosis Nos/Other
Interventions: iTBS (Active), iTBS (Sham); Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 39 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Glen Oaks, New York

Conditions: Charcot-Marie-Tooth Disease
Interventions: (RS)-baclofen, naltrexone hydrochloride and D-sorbitol, Placebo; Drug
Lead sponsor: Pharnext S.C.A.; Other
Eligibility: 16 Years to 65 Years
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 20
States / cities: Los Angeles, California • Sacramento, California • New Britain, Connecticut + 16 more

Conditions: Obesity, Morbid, Surgery, Bariatric Surgery Candidate
Interventions: Neurontin, Dilaudid Injectable Product, Marcaine Injectable Product, Oxycodone Hydrochloride, Hycet 7.5Mg-325Mg/15Ml Solution, Zofran Injection, Scopolamine patch, Ativan, Flexeril Oral Product, Tylenol Suspension; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 35 Years to 65 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Rupture of Amniotic Membranes
Interventions: Sterile speculum exam, ROM Plus Exam, Chart Reveiw; Procedure
Lead sponsor: Clinical Innovations, LLC; Industry
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 288 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Allergic Rhinitis, Upper Respiratory Infection
Interventions: Doxylamine Succinate USP; Drug
Lead sponsor: Procter and Gamble; Industry
Eligibility: 2 Years to 18 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 6
States / cities: Washington D.C., District of Columbia • Louisville, Kentucky • Shreveport, Louisiana + 3 more

Conditions: Primary Central Nervous System Lymphoma (PCNSL)
Interventions: Nivolumab; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Alcohol Use Disorder, Sexually Transmitted Diseases
Interventions: Standardized kudzu, Placebo, Sexually transmitted infection testing:, Medical Management (MM) counseling for alcohol use:, Urinalysis for novel alcohol biochemical markers for recent alcohol use:, Dried Blood Spot (DBS) Testing for PEth:, Behavioral survey measurements:, Ecological Momentary Assessment procedure:; Drug · Other · Diagnostic Test + 1 more
Lead sponsor: Glenn-Milo Santos; Other
Eligibility: 18 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Erythema, Sensitisation
Interventions: CB-0002B; Other
Lead sponsor: CAGE Bio Inc.; Industry
Eligibility: 21 Years to 67 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: New City, New York

Conditions: Anesthesia, Aspiration, Fasting
Interventions: Addition of half and half to coffee, Addition of non-dairy creamer to coffee, Black; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Vascular Access Complication
Interventions: AccuCath IV Catheter Device, Conventional IV Catheter Device; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Congestive Heart Failure
Interventions: Beta blocker (carvedilol or metoprolol succinate), CRT (cardiac resynchronization therapy); Drug · Procedure
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 3
States / cities: New York, New York • Rochester, New York • Philadelphia, Pennsylvania

Conditions: Relapsing Remitting Multiple Sclerosis
Interventions: Helminth ova; Biological
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 50 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Amyotrophic Lateral Sclerosis, Parkinson Disease, Dysphagia
Interventions: Videofluoroscopic Swallowing Examination, Tongue Strength Measurement; Diagnostic Test · Other
Lead sponsor: University Health Network, Toronto; Other
Eligibility: 18 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Autism Spectrum Disorder
Interventions: Folinic Acid, Placebo; Drug · Other
Lead sponsor: Southwest Autism Research & Resource Center; Other
Eligibility: 5 Years to 17 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 4
States / cities: Phoenix, Arizona • Atlanta, Georgia • Lexington, Massachusetts + 1 more

Conditions: Infection, Soft Tissue, Infection, Wound, Cellulitis, Diabetic Foot Ulcer
Interventions: Cefazolin, Silberg Tissue Preparation System; Drug · Device
Lead sponsor: Sonescence, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Sebastopol, California

Conditions: Ovarian Aging, In Vitro Fertilisation (IVF) Treatment, InVitro Fertilization, In Vitro Fertilization Outcome
Interventions: No Interventions; Other
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Upper Respiratory Tract Infections
Interventions: Hyland's Cold 'n Cough 4 kids, placebo; Drug
Lead sponsor: University of Washington; Other
Eligibility: 2 Years to 5 Years
Enrollment: 263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Back Pain
Interventions: Myelogram; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 64 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Respiratory Distress Syndrome, Adult, Lung Diseases
Interventions: Low Tidal Volume Ventilation, Positive End-Expiratory Pressure, Lysofylline, Methylprednisolone, Ketoconazole, Fluid Management, Pulmonary Artery Catheter; Procedure · Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 13 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 2004
U.S. locations: 20
States / cities: San Francisco, California • Denver, Colorado • Chicago, Illinois + 17 more

Conditions: Osteoarthritis
Interventions: Arthroscopy, Arthroplasty; Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Congenital Diaphragmatic Hernia
Interventions: BALT GOLDBALL 2 detachable latex ballon, BALTACCIBDPE100 Microcatheter, Storz fetoscopic operating sheath and miniature telescope/fetoscope; Device
Lead sponsor: Mauro H. Schenone; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2043
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Osteoarthritis, Articular Cartilage, Musculoskeletal Disorders
Interventions: Platelet-Rich Plasma (PRP) Injections, Centrifuge, Control saline injection; Drug · Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Diabetes, Obesity
Interventions: Pre-study dietary and exercise instruction., Screening examination and oral glucose tolerance test, Euglycemic clamp, VO2max., Acute exercise bout, Percutaneous needle muscle biopsies; Behavioral · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 59 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Urea Cycle Disorders
Interventions: HPN-100; Drug
Lead sponsor: Amgen; Industry
Eligibility: 29 Days to 6 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 8
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Portland, Maine + 5 more

Search by objective public record fields.

iTBS to Enhance Social Cognition in People With Psychosis

Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients

Multimodal Analgesia Effect on Post Surgical Patient

Analysis of ROM Plus to Detect Rupture of Membranes

Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children

Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy

Addressing Heavy Alcohol Use Consumption With Kudzu

50 Human Subject Repeat Insult Patch Test

How do You Take Your Coffee Before Anesthesia

AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use

BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)

Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis

Physiological Flow of Liquids Used in Dysphagia Management (Neuro)

Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion

Follicular Fluid microRNAs in Ovarian Aging and Reproduction

Homeopathic Cold Remedy for Children Study

Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning

Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)

Evaluation of Biomarkers in Human Synovial Fluid

Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Platelet Rich Plasma Injections In Young And Old Human Subjects

PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes

Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)